#HCPLive
A new international SkinObservatory study presented at #EADV2026 reveals that 42% of countries report climate-related worsening of skin diseases, with lower-income nations hit hardest.

tinyurl.com/yc858889 #ClimateChange #Dermatology #Skin #Health
Climate Change Tied to Skin Disease Worsening in 42% of Countries | HCPLive
The international SkinObservatory study found climate-related skin disease disproportionately affecting low-income nations at EADV 2026.
tinyurl.com
October 1, 2026 at 1:08 AM
Mainstream medicine completely forgot other hormones bind to the MR. Huge TriNetX database analysis of heart failure cohorts shows spironolactone use drops Alzheimer's risk by 18% and dementia by 9% over 3 years. It is a protective tissue shield crossing the BBB, not just a water pill. #rs5522
In Heart Failure Patients, Spironolactone Linked to Reduced Risk of Dementia, Alzheimers Disease | HCPLive
A propensity score-matched analysis of data suggests use of spironolactone could reduce the 3-year risk of developing Alzheimer disease or dementia among patients with heart failure with reduced eject...
www.hcplive.com
September 24, 2026 at 3:58 PM
Kidney Organoids May Speed AKI Drug Screening, With Alexander Combes, PhD | HCPLive - goo.gl/alerts/yiWPjz #GoogleAlerts
Kidney Organoids May Speed AKI Drug Screening, With Alexander Combes, PhD | HCPLive
Alexander Combes, PhD, discusses how kidney organoids could be used to screen and repurpose drugs for acute kidney injury.
goo.gl
September 11, 2026 at 10:37 AM
Mistaken for a UTI: Diagnosing IgA Nephropathy, With Gaia Coppock, MD | HCPLive - goo.gl/alerts/eUHJhq #GoogleAlerts
Mistaken for a UTI: Diagnosing IgA Nephropathy, With Gaia Coppock, MD | HCPLive
A survey of patients with IgA nephropathy shows how nonspecific symptoms and long referral waits delay diagnosis by up to two years.
goo.gl
September 11, 2026 at 10:11 AM
Redefining Treatment Success in IgAN: Remission and Life Beyond Steroids - HCPLive - goo.gl/alerts/qPNXF6 #GoogleAlerts
Redefining Treatment Success in IgAN: Remission and Life Beyond Steroids | HCPLive
This episode, "Redefining Treatment Success in IgAN: Remission and Life Beyond Steroids," features the panel reframing the goals of care.
goo.gl
September 9, 2026 at 5:46 PM
The Next Five Years in Psoriasis: Remission, Access, and Combinations - HCPLive - goo.gl/alerts/Ma2bZp #GoogleAlerts
The Next Five Years in Psoriasis: Remission, Access, and Combinations | HCPLive
In "The Next Five Years in Psoriasis: Remission, Access, and Combinations," the panel looks ahead to the advances and the unfinished work of the coming years.
goo.gl
September 9, 2026 at 9:05 AM
Ixekizumab-Tirzepatide Sustains 1-Year Gains in Psoriatic Disease, Obesity | HCPLive - goo.gl/alerts/Mh7gwC #GoogleAlerts
Ixekizumab-Tirzepatide Sustains 1-Year Gains in Psoriatic Disease, Obesity | HCPLive
At Week 52, ixekizumab plus tirzepatide sustained gains in skin clearance, joint response and metabolic measures versus ixekizumab alone.
goo.gl
September 5, 2026 at 11:32 AM
Why Chronic Kidney Disease Treatment Should Start Earlier, Last Longer for Incarcerated Persons
www.hcplive.com/view/ckd-tre...
Why CKD Treatment Should Start Earlier, Last Longer for Incarcerated Persons | HCPLive
Laura J. Maursetter, MD, discusses why early kidney disease screening and continuity of care are especially critical for justice-involved patients.
www.hcplive.com
August 31, 2026 at 1:55 PM
Signal or noise? > Spotlight on Gene and Molecular Therapies at ESC 2026, With
Steven Nissen, MD - HCPLive >> Comment below! #strategy #competitiveintelligence #marketing #pharma #biotech #competitivemarketing #healthcare #pharmaceutical
Spotlight on Gene and Molecular Therapies at ESC 2026, With Steven Nissen, MD - HCPLive
Spotlight on Gene and Molecular Therapies at ESC 2026, With Steven Nissen, MD  HCPLive
dlvr.it
August 29, 2026 at 2:25 PM
IgAN Pathogenesis and the Rationale for Complement Inhibition - HCPLive - goo.gl/alerts/omeaYD #GoogleAlerts
IgAN Pathogenesis and the Rationale for Complement Inhibition | HCPLive
In "IgAN Pathogenesis and the Rationale for Complement Inhibition," our experts connect disease mechanism to drug targets.
goo.gl
August 27, 2026 at 11:01 AM
Rethinking IgA Nephropathy Risk and Treatment, With Ali Mehdi, MD, MEd | HCPLive - goo.gl/alerts/9rYhnr #GoogleAlerts
Rethinking IgA Nephropathy Risk and Treatment, With Ali Mehdi, MD, MEd | HCPLive
Rethinking IgA Nephropathy Risk and Treatment, With Ali Mehdi, MD, MEd
goo.gl
August 27, 2026 at 10:58 AM
Psoriasis Awareness & Action Month: New Oral Drugs and Other Developments | HCPLive - goo.gl/alerts/2hR1Zc #GoogleAlerts
Psoriasis Awareness & Action Month: New Oral Drugs and Other Developments | HCPLive
Saakshi Khattri, MD, discusses oral TYK2 inhibitor and IL-23 antagonist data alongside weight-loss combination therapy reshaping psoriasis and PsA care.
goo.gl
August 27, 2026 at 10:33 AM
CKD Care Gaps for Incarcerated Patients, With Laura Maursetter, MD | HCPLive - goo.gl/alerts/QdxC6v #GoogleAlerts
CKD Care Gaps for Incarcerated Patients, With Laura Maursetter, MD | HCPLive
A nephrologist details gaps in tracking CKD screening, labs, and treatment in correctional care.
goo.gl
August 26, 2026 at 2:49 PM
Real-World Evidence and Systemic Inflammation in Psoriasis - HCPLive - goo.gl/alerts/Mh7rN3 #GoogleAlerts
Real-World Evidence and Systemic Inflammation in Psoriasis | HCPLive
In "Real-World Evidence and Systemic Inflammation in Psoriasis," our experts scrutinize the evidence behind popular claims about disease progression.
goo.gl
August 24, 2026 at 12:20 PM
Kidney Compass: VISIONARY 2-Year eGFR Data in IgA Nephropathy - HCPLive - goo.gl/alerts/jkrVfq #GoogleAlerts
Kidney Compass: VISIONARY 2-Year eGFR Data in IgA Nephropathy | HCPLive
Dana Rizk, MD, joins hosts Brendon Neuen and Shikha Wadhwani to unpack 2-year VISIONARY data showing sibeprenlimab stabilizes eGFR in IgAN.
goo.gl
August 15, 2026 at 7:39 AM
Rethinking CKD: AKI's Long-Term Impact and the Push for Earlier Intervention
www.hcplive.com/view/rethink...
Rethinking CKD: AKI's Long-Term Impact and the Push for Earlier Intervention | HCPLive
Matthew Breeggemann, MD, of UCSF discusses genetic testing, risk stratification, and the future of personalized CKD management in 2026.
www.hcplive.com
August 12, 2026 at 12:10 PM
Closing Gaps in IgA Nephropathy Diagnosis and Treatment, With Brad Rovin, MD | HCPLive - goo.gl/alerts/eF5imc #GoogleAlerts
Closing Gaps in IgA Nephropathy Diagnosis and Treatment, With Brad Rovin, MD | HCPLive
Brad Rovin, MD, discusses gaps in IgA nephropathy care, biopsy's expanding role, and how new B cell therapies are reshaping treatment.
goo.gl
August 12, 2026 at 9:57 AM
May be it has something to do with abusing DDT and then my generation being born with lots of issues then eating stuff grown in a soil full of the DDT that takes 15 years to break down to DDE and DDD which are equally or even more dangerous.

www.hcplive.com/view/prenata...
August 11, 2026 at 7:17 AM